iatroX logo
brainstormaskiatroXuk q-bankus q-bankknowledge centreblog
Knowledge Centre / Reactive Arthritis

Reactive Arthritis

Diagnosis and management.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Rheumatology

Clinical Guidelines

British Association of Sexual Health and HIV national guideline on the management of sexually acquired reactive arthritis
National
European guideline for the management of sexually acquired reactive arthritis
National
NICE guideline [NG100]
National
2016 update of the EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies
Local
British Association of Sexual Health and HIV national guideline on the management of sexually acquired reactive arthritis 2021
Local

Recent iatroX Q&As

  • Which laboratory tests are most useful in confirming a diagnosis of reactive arthritis in a primary care setting?Updated: 8/16/2025
  • What are the recommended first-line treatments for managing reactive arthritis in adults?Updated: 8/16/2025
  • When should I consider referring a patient with reactive arthritis to a rheumatologist?Updated: 8/16/2025
  • How can I effectively educate patients about the potential triggers and long-term management of reactive arthritis?Updated: 8/16/2025
askiatroX
privacytermshow it workscpdinsightsfaqabout
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play